Study of the analgesic effects of repeated doses of F13640 in spinal cord injury patients with moderate to severe central neuropathic pain. A multinational, multicenter, randomized, double blind, parallel groups, placebo-controlled study.
Study of the analgesic effects of repeated doses of F13640 in spinal cord injury patients with moderate to severe central neuropathic pain. A multinational, multicenter, randomized, double blind, parallel groups, placebo-controlled study.
Study of the analgesic effects of repeated doses of F13640 in spinal cord injury patients with moderate to severe central neuropathic pain. A multinational, multicenter, randomized, double blind, parallel groups, placebo-controlled study.
Status
Status :
Completed
Type of study
Phase II
Min. Age
18
Years old
Max. Age
65
Years old
Gender
All
Therapeutic area :
Central Nervous System
Disease :
Neuropathy
Study medication :
F13640
Phase :
Phase II
Start Date :
19 February 2008
End date :
03 December 2008
Study ID :
F13640 GE 210
EudraCT/CTIS number :
2007-003230-42
Send by email